<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:16:44Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9157340" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9157340</identifier>
        <datestamp>2022-06-16</datestamp>
        <setSpec>bmjo</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMJ Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id>
              <journal-id journal-id-type="hwp">bmjopen</journal-id>
              <journal-id journal-id-type="publisher-id">bmjopen</journal-id>
              <journal-title-group>
                <journal-title>BMJ Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2044-6055</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9157340</article-id>
              <article-id pub-id-type="pmcid">PMC9157340</article-id>
              <article-id pub-id-type="pmc-uid">9157340</article-id>
              <article-id pub-id-type="pmid">35641012</article-id>
              <article-id pub-id-type="pmid">35641012</article-id>
              <article-id pub-id-type="publisher-id">bmjopen-2022-061373</article-id>
              <article-id pub-id-type="doi">10.1136/bmjopen-2022-061373</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Rehabilitation Medicine</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                  <subject>1727</subject>
                </subj-group>
                <series-title>Original research</series-title>
              </article-categories>
              <title-group>
                <article-title>Randomised controlled trial of a behaviour change physiotherapy intervention to increase physical activity following hip and knee replacement: the PEP-TALK trial</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-68613053" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Smith</surname>
                    <given-names>Toby O</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-73475659" contrib-type="author">
                  <name>
                    <surname>Parsons</surname>
                    <given-names>Scott</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-73475712" contrib-type="author">
                  <name>
                    <surname>Ooms</surname>
                    <given-names>Alexander</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-35164028" contrib-type="author">
                  <name>
                    <surname>Dutton</surname>
                    <given-names>Susan</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-64161684" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5996-3563</contrib-id>
                  <name>
                    <surname>Fordham</surname>
                    <given-names>Beth</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-60551147" contrib-type="author">
                  <name>
                    <surname>Garrett</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-73475762" contrib-type="author">
                  <name>
                    <surname>Hing</surname>
                    <given-names>Caroline</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-34994179" contrib-type="author">
                  <name>
                    <surname>Lamb</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <collab>the PEP-TALK Trial Collaborators
<contrib-group content-type="collaborators"><contrib contrib-type="collab"><name><surname>Algar</surname><given-names>Steve</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hansen</surname><given-names>Zara</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Barber</surname><given-names>Vicki</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hart</surname><given-names>Malcolm</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Png</surname><given-names>MayEe</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Barker</surname><given-names>Karen</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Smith</surname><given-names>Ian</given-names></name></contrib><contrib contrib-type="collab"><name><surname>McNamara</surname><given-names>Iain</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Dunn</surname><given-names>Michael</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Lockey</surname><given-names>Dawn</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Driver</surname><given-names>Sonny</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Kassam</surname><given-names>Jamila</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Penny</surname><given-names>Peter</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Woodhouse</surname><given-names>Celia</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Potter</surname><given-names>Tracey</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Daniell</surname><given-names>Helena</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Herring</surname><given-names>Alex</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Cunningham</surname><given-names>Yan</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Afzal</surname><given-names>Irrum</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Matharu</surname><given-names>Maninderpal</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hughes</surname><given-names>Tamsin</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hannink</surname><given-names>Erin</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Moynihan</surname><given-names>Michelle</given-names></name></contrib></contrib-group>
</collab>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences</institution>, <institution>University of Oxford</institution>, <addr-line content-type="city">Oxford</addr-line>, <country>UK</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">School of Health Sciences</institution>, <institution>University of East Anglia</institution>, <addr-line content-type="city">Norwich</addr-line>, <country>UK</country></aff>
              <aff id="aff3"><label>3</label><institution content-type="department">Centre for Statistics in Medicine</institution>, <institution>University of Oxford</institution>, <addr-line content-type="city">Oxford</addr-line>, <country>UK</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Trauma and Orthopaedic Department</institution>, <institution>St George's University Hospitals NHS Foundation Trust</institution>, <addr-line content-type="city">London</addr-line>, <country>UK</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">College of Medicine and Health</institution>, <institution>University of Exeter</institution>, <addr-line content-type="city">Exeter</addr-line>, <country>UK</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Dr Toby O Smith; <email>toby.smith@uea.ac.uk</email>
</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>31</day>
                <month>5</month>
                <year>2022</year>
              </pub-date>
              <volume>12</volume>
              <issue>5</issue>
              <elocation-id>e061373</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>1</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>05</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <ali:free_to_read/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense" start_date="2022-05-31">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="bmjopen-2022-061373.pdf"/>
              <self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2022-061373.reviewer_comments.pdf"/>
              <self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2022-061373.draft_revisions.pdf"/>
              <abstract>
                <sec>
                  <title>Objective</title>
                  <p>To test the effectiveness of a behaviour change physiotherapy intervention to increase physical activity compared with usual rehabilitation after total hip replacement (THR) or total knee replacement (TKR).</p>
                </sec>
                <sec>
                  <title>Design</title>
                  <p>Multicentre, pragmatic, two-arm, open, randomised controlled, superiority trial.</p>
                </sec>
                <sec>
                  <title>Setting</title>
                  <p>National Health Service providers in nine English hospitals.</p>
                </sec>
                <sec>
                  <title>Participants</title>
                  <p>224 individuals aged ≥18 years, undergoing a primary THR or TKR deemed ‘moderately inactive’ or ‘inactive’.</p>
                </sec>
                <sec>
                  <title>Intervention</title>
                  <p>Participants received either six, 30 min, weekly, group-based exercise sessions (usual care) or the same six weekly, group-based, exercise sessions each preceded by a 30 min cognitive behaviour discussion group aimed at challenging barriers to physical inactivity following surgery (experimental).</p>
                </sec>
                <sec>
                  <title>Randomisation and blinding</title>
                  <p>Initial 75 participants were randomised 1:1 before changing the allocation ratio to 2:1 (experimental:usual care). Allocation was based on minimisation, stratifying on comorbidities, operation type and hospital. There was no blinding.</p>
                </sec>
                <sec>
                  <title>Main outcome measures</title>
                  <p>Primary: University of California Los Angeles (UCLA) Activity Score at 12 months. Secondary: 6 and 12-month assessed function, pain, self-efficacy, kinesiophobia, psychological distress and quality of life.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Of the 1254 participants assessed for eligibility, 224 were included (139 experimental: 85 usual care). Mean age was 68.4 years (SD: 8.7), 63% were women, 52% underwent TKR. There was no between-group difference in UCLA score (mean difference: −0.03 (95% CI −0.52 to 0.45, p=0.89)). There were no differences observed in any of the secondary outcomes at 6 or 12 months. There were no important adverse events in either group. The COVID-19 pandemic contributed to the reduced intended sample size (target 260) and reduced intervention compliance.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>There is no evidence to suggest attending usual care physiotherapy sessions plus a group-based behaviour change intervention differs to attending usual care physiotherapy alone. As the trial could not reach its intended sample size, nor a proportion of participants receive their intended rehabilitation, this should be interpreted with caution.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p><ext-link xlink:href="ISRCTN29770908" ext-link-type="isrctn">ISRCTN29770908</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>rheumatology</kwd>
                <kwd>adult orthopaedics</kwd>
                <kwd>hip</kwd>
                <kwd>knee</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float">
              <caption>
                <title>Strengths and limitations of this study</title>
              </caption>
              <list list-type="bullet">
                <list-item>
                  <p>The multicentre recruitment approach enhanced external validity across population characteristics in England.</p>
                </list-item>
                <list-item>
                  <p>Functional, behavioural and psychological outcomes were collected to ensure a global participant assessment.</p>
                </list-item>
                <list-item>
                  <p>It was challenging to ensure that there were acceptable numbers of people in the group-based intervention.</p>
                </list-item>
                <list-item>
                  <p>All 12-month follow-up data were collected during the COVID-19 pandemic, potentially impacting on typical recovery and psychological outcomes.</p>
                </list-item>
                <list-item>
                  <p>The COVID-19 pandemic meant we were unable to reach our anticipated sample size or deliver the intervention as planned.</p>
                </list-item>
              </list>
            </boxed-text>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Total hip replacement (THR) and total knee replacement (TKR) are two highly successful orthopaedic procedures, which reduce pain for people with osteoarthritis.<xref rid="R1" ref-type="bibr">1 2</xref> Over 200 000 THRs and TKRs were performed in the United Kingdom (UK) in 2019 prepandemic.<xref rid="R1" ref-type="bibr">1</xref> Approximately 90% of patients are typically satisfied following THR and TKR,<xref rid="R2" ref-type="bibr">2</xref> with significant improvements in pain and physical function after 3–12 months.<xref rid="R2" ref-type="bibr">2 3</xref>
</p>
              <p>Historically, it has been assumed that people become more active following THR or TKR through the amelioration of joint pain.<xref rid="R4" ref-type="bibr">4</xref> However, current literature suggests physical activity, at best, remains the same from preoperatively to postoperatively, and in some instances declines.<xref rid="R4" ref-type="bibr">4 5</xref>
</p>
              <p>People following THR and TKR have reported a number of challenges which make engaging in physical activity difficult, most notably psychosocial barriers and fear avoidance beliefs.<xref rid="R6" ref-type="bibr">6</xref> Such barriers include receiving insufficient and inconsistent information on being more physically active, fear of damaging joint replacements and causing pain and not being able to goalset or problemsolve physical activities within individual’s lifestyles.<xref rid="R6" ref-type="bibr">6</xref> While previous international guidance has acknowledged the importance of physical activity on health and well-being, people following THR and TKR have reported difficulty in being active.<xref rid="R6" ref-type="bibr">6</xref> There is limited support or guidance currently offered on how to overcome these problems post-operatively.<xref rid="R6" ref-type="bibr">6</xref>
</p>
              <p>Not being physically active after joint replacement can have a major negative impact on a person’s health and a burden on the National Health Service (NHS). Medical comorbidities are common in this population. These include hypertension (56%),<xref rid="R7" ref-type="bibr">7</xref> cardiovascular disease (20%),<xref rid="R8" ref-type="bibr">8</xref> diabetes (16%)<xref rid="R8" ref-type="bibr">8</xref> and multijoint pain (57%).<xref rid="R7" ref-type="bibr">7</xref> Approximately, 27% of people who undergo joint replacement have three or four comorbidities.<xref rid="R8" ref-type="bibr">8</xref> Medical comorbidities have a significant negative impact on both health-related quality of life (HRQoL) and result in a societal burden.<xref rid="R9" ref-type="bibr">9 10</xref> Participating in regular physical activity can decrease the risk of cardiovascular disease by 52%,<xref rid="R11" ref-type="bibr">11</xref> diabetes by 65%<xref rid="R12" ref-type="bibr">12</xref> and some cancers by 40%.<xref rid="R13" ref-type="bibr">13</xref> It is associated with a reduction in all-cause mortality by 33% and cardiovascular mortality by 35%.<xref rid="R14" ref-type="bibr">14</xref>
</p>
              <p>Current rehabilitation following THR and TKR in the UK, as advocated by the National Institute for Health and Care Excellence, centres around regaining joint movement, strength and gait re-education.<xref rid="R15" ref-type="bibr">15</xref> There is currently no evidence informing patients or healthcare professionals on how to increase physical activity specifically following THR and TKR. Following joint replacement, people have specific psychological needs and challenges, which differ to the non-joint replacement population.<xref rid="R6" ref-type="bibr">6</xref> Therefore, a specific intervention tailored to this population’s health beliefs, including fear avoidance regarding implant survival, dislocation and increased knowledge on the impact of physical inactivity on other comorbidities, is required. Previous research has demonstrated that behaviour–change interventions can effectively increase physical activity across the lifespan.<xref rid="R16" ref-type="bibr">16–20</xref> Given this, it was hypothesised that such an intervention could be beneficial for this population. Accordingly, the purpose of this trial was to answer the research question ‘following a primary THR or TKR, does a group exercise and behaviour-change intervention targeted to increase physical activity participation increase HRQoL and clinical outcomes over the initial 12 postoperative months compared with group exercise alone?’</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2-1">
                <title>Study design</title>
                <p>A full protocol has been published previously.<xref rid="R21" ref-type="bibr">21</xref>
</p>
                <p>This was a two-arm, open, pragmatic, parallel, multicentre, randomised controlled superiority trial. The study flowchart is presented as <xref rid="F1" ref-type="fig">figure 1</xref>. Participants were recruited from eight UK NHS hospital trusts by the clinical team once they had been listed for THR or TKR. Interventions were delivered in physiotherapy departments within these NHS facilities.</p>
                <fig position="float" id="F1">
                  <label>Figure 1</label>
                  <caption>
                    <p>CONSORT flowchart. CONSORT, Consolidated Standards of Reporting Trials.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2022-061373f01" position="float"/>
                </fig>
                <p>We recruited adults who were due to undergo primary unilateral THR or TKR where the indication for surgery was degenerative joint pathology (not trauma). Potential participants were classified as ‘moderately inactive’ or ‘inactive’ using the General Practice Physical Activity Questionnaire<xref rid="R22" ref-type="bibr">22</xref> and have a Charlson Comorbidity Index (CCI) of ≥1 point.<xref rid="R23" ref-type="bibr">23 24</xref> We excluded people who were cognitively impaired, defined as an Abbreviated Mental Test Score (AMTS)<xref rid="R25" ref-type="bibr">25</xref> of &lt;8; whose usual place of residence was a care home; were unable to read and/or comprehend English and had no access to a working telephone.</p>
              </sec>
              <sec id="s2-2">
                <title>Study treatments</title>
                <p>Usual NHS surgical and in-patient care was received by both control and intervention groups. On hospital discharge, all participants attended 6 weekly, 30 min, group-based exercise classes within each hospital trust’s physiotherapy department. These groups commenced within 4 weeks postoperation. The principles regarding prescription of group exercises to increase range of motion, strength and gait pattern, were consistent. While the rehabilitation of THR and TKR focuses on overall lower limb function, all participants following a THR focused on hip exercises, whereas those following a TKR focused on knee exercises. One physiotherapist (with or without a second physiotherapist or therapy assistant) ran each session.</p>
                <p>The programme and rationale for the experimental intervention are presented in detail in <xref rid="SP1" ref-type="supplementary-material">online supplemental file 1</xref>. In brief, the intervention was grounded in the social cognitive theory<xref rid="R26" ref-type="bibr">26</xref> based on the theory that behaviour (physical activity level) is influenced by bidirectional relationships with personal factors (cognitive, emotional and physical) and environment. In this process, the cognitive behavioural approach in the PEP-TALK intervention used techniques to identify and target unhelpful thoughts and behaviours in order to produce adaptive thoughts, behaviours, emotions and physiological responses. Previous systematic reviews examining barriers and facilitators for older adults to increase physical activity have identified specific beliefs, which could reduce an individual’s general self-efficacy.<xref rid="R4" ref-type="bibr">4 6 27 28</xref> These include: stigma, body image<xref rid="R28" ref-type="bibr">28</xref> and ageing stereotypes.<xref rid="R27" ref-type="bibr">27</xref> Unhelpful beliefs can be identified and explored using cognitive behavioural techniques to increase self-efficacy. The evidence also identified tools to increase general self-efficacy, which include the credibility of instructors and the information/physical activity tasks they provide.<xref rid="R27" ref-type="bibr">27–29</xref> The PEP-TALK intervention was designed to address these, exploring known barriers and facilitators to physical activity after joint replacement,<xref rid="R6" ref-type="bibr">6</xref> to promote increased participation in activity postoperatively.</p>
                <supplementary-material id="SP1" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/bmjopen-2022-061373.supp1</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS1" xlink:href="bmjopen-2022-061373supp001.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
                <p>In practice, participants randomised to the experimental group received the same 6 weekly, group-based, 30 min, exercise session as the usual care group. The only difference between the two groups was the addition of a 30 min, group-based, behaviour change intervention prior to the routine 30 min of exercise, and three follow-up telephone calls 2, 4 and 6 weeks after the last group-based session. In the group-based sessions, participants were facilitated (as a group) to develop skills to overcome challenges to physical activity behaviour, supplemented through a workbook. This encouraged reflective activities such as recording physical, emotional and cognitive barriers and facilitators to physical activity. One physiotherapist (with or without a second physiotherapist or therapy assistant) ran each session. During the follow-up telephone calls, participant’s goals were reviewed, any barriers to the completion of these goals were identified, and the physiotherapist reviewed any ‘unhelpful’ and ‘helpful’ thoughts or feelings towards physical activity, which may have arisen since the last consultation and closed with the development of longer term physical activity goal setting. A treatment log was completed by physiotherapists to record the components of what was discussed across the group in each session and each telephone call.</p>
                <p>Each member delivering the experimental intervention attended a 1-day training session, which taught the components and format of the intervention. To ensure compliance with the treatment protocol, the PEP-TALK team made regular visits for quality assurance.</p>
              </sec>
              <sec id="s2-3">
                <title>Data collection</title>
                <p>At the time of enrolment, site healthcare professionals checked eligibility and recorded demographic characteristics. Baseline scores for outcome questionnaires were obtained before randomisation. Data collected at baseline included: gender, age, height and weight, CCI, self-reported presence and location of multisite joint pain, comorbidities determined from the medical notes, AMTS, employment status and occupation (when appropriate).</p>
                <p>Participants were followed-up at 6 and 12 months after randomisation.</p>
                <p>The primary outcome was the University of California Los Angeles (UCLA) Activity Score<xref rid="R30" ref-type="bibr">30</xref> (scored 0–10; higher scores indicate greater physical activity) at 12 months. This was selected as it is a reliable and valid self-reported tool to assess physical activity<xref rid="R31" ref-type="bibr">31</xref> and has been previously used for this means in orthopaedic trials.<xref rid="R32" ref-type="bibr">32</xref> Secondary outcomes at 6 and 12 months after randomisation were measured using the Lower Extremity Functional Scale (LEFS)<xref rid="R33" ref-type="bibr">33</xref> (scored 0 to 80, higher scores indicating less functional disability), Oxford Hip Score (OHS)<xref rid="R34" ref-type="bibr">34</xref> or Oxford Knee Score (OKS)<xref rid="R35" ref-type="bibr">35</xref> (scored 0–48, higher scores indicating less disease-specific function), Numerical Rating Scale (NRS) for pain (scored 0–10, higher scores indicating greater pain perception), the Generalized Self-Efficacy Scale (GSES)<xref rid="R36" ref-type="bibr">36</xref> (scored 10–40, higher scores indicating greater self-efficacy), the Tampa Scale for Kinesiophobia<xref rid="R37" ref-type="bibr">37</xref> (scored 17–68, higher scores indicating greater fear of motion), the Hospital Anxiety and Depression Scale (HADS)<xref rid="R38" ref-type="bibr">38</xref> (scored 0–21, higher scores indicating greater anxiety and depression), and the EQ-5D-5L<xref rid="R39" ref-type="bibr">39</xref> (scored 0–1, higher scores indicating greater HRQoL). Participants provided a retrospective assessment of complications at each 6-month follow-up period. Health resource utilisation data were collected but are not presented in this paper.</p>
                <p>For each participant in the experimental intervention arm, the number of trial exercise sessions attended and group size of each session was recorded. The number of telephone contacts made after the end of the sessions and adherence with intervention protocols was also collected. There were no changes to the outcomes during the trial.</p>
              </sec>
              <sec id="s2-4">
                <title>Randomisation and masking</title>
                <p>Random allocation was 1:1 originally. Randomisation was performed using a centralised computer randomisation programme provided by the Oxford Clinical Trials Research Unit (OCTRU). Research nurses and physiotherapists at recruiting centres enrolled participants and then assigned participants by accessing the online OCTRU randomisation programme, thereby adopting a concealed allocation approach. Randomisation was undertaken using a minimisation algorithm, stratified by: hospital site; type of joint replacement (THR or TKR); CCI of one to three versus ≥4.<xref rid="R23" ref-type="bibr">23 24</xref> It had a probabilistic element introduced to ensure unpredictability of treatment assignment.</p>
                <p>The experimental intervention was designed to have three or more people per group.<xref rid="R21" ref-type="bibr">21</xref> Early sites found it difficult to consistently reach this level of participant numbers with the original 1:1 randomisation allocation. Accordingly, after 75 randomisations, we modified the randomisation ratio to 2:1 in favour of the experimental intervention. This ensured that a greater number of people are allocated to the experimental intervention. The sample size was increased to 260 to account for this change.</p>
                <p>Masking participants or the teams providing interventions was not possible.</p>
              </sec>
              <sec id="s2-5">
                <title>Sample size</title>
                <p>The trial was powered on the single primary outcome of UCLA at 12 months. Originally, 250 participants (125 per arm) were required to detect a standardised effect size of 0.4 with 80% power and 5% (two sided) significance, and allowing for 20% loss to follow-up. These calculations were based on the primary outcome, UCLA Activity Score at 12 months, assuming a baseline SD of 2.5 and a between-group difference of one.<xref rid="R32" ref-type="bibr">32</xref> The minimally clinically important difference (MCID) was reported as a within-person difference of 0.92 points.<xref rid="R32" ref-type="bibr">32</xref>
</p>
                <p>The target sample size was increased to 260 to account for the change in randomisation ratio.<xref rid="R21" ref-type="bibr">21</xref>
</p>
                <p>Results from the secondary outcomes provide supporting evidence for the results from the primary outcome analysis and are not powered separately. No allowance for multiple testing was included as a single primary outcome was considered.</p>
              </sec>
              <sec id="s2-6">
                <title>Statistical methods</title>
                <p>There was no planned interim analyses or predefined stopping rules. Full analysis details are in the published statistical analysis plan.<xref rid="R40" ref-type="bibr">40</xref>
</p>
                <p>The primary outcome measure, UCLA at 12 months, was modelled using a linear mixed effect model adjusting for person within centre random effects, CCI, type or operation (TKR or THR), time (6 and 12 months) and baseline UCLA score as fixed effects using the intention-to-treat population (participants analysed as randomised). A treatment by time point interaction was included to allow time-specific treatment effects to be calculated. This approach makes use of all available data at each time point. The secondary outcomes (LEFS, OKS, OHS, HADS, NRS for pain, GSES, Tampa, EQ-5D-5L Index and EQ-VAS) were analysed using a similar modelling approach. The number of participants with one or more complications were analysed using logistic regression, adjusting for minimisation factors and treatment. A total number of complications were analysed using Poisson Regression adjusting for the same factors.</p>
                <p>Supporting analyses to the primary outcome included an area under the curve (AUC) analysis and complier average causal effect (CACE) analyses for all three predefined levels of compliance (Strict Compliance, Compliance, Attendance).<xref rid="R40" ref-type="bibr">40</xref> Full definitions of the three compliance levels are given in <xref rid="SP1" ref-type="supplementary-material">online supplemental file 2</xref>. The AUC analysis provided additional information on the trajectory of function recovery of these participants. The CACE analysis answered the question, for those participants who received the intervention as planned, did it improve function over usual care alone? The AUC analysis was performed using the same model as used for the primary analysis except including baseline UCLA Activity Score in the ‘time’-fixed effect allowing time point-specific treatment effects to be calculated for baseline, 6 and 12 months. The CACE analysis has been performed through 10 000 bootstrapped samples. Adjusted linear regression was used for the 12-month UCLA Activity Score; adjusting for randomised treatment, baseline UCLA Activity Score, recruiting site, CCI (continuous) and joint replacement was used to obtain Intention To Treat (ITT) estimates. The pathway from treatment allocation to compliance (rate of potential compliers in the usual care group) was also estimated using adjusted linear regression: compliance indicators was analysed adjusting for the same variables. CACE estimates were obtained by taking the ratio of the ITT estimate and potential complier rate. SEs, CI and p values were calculated using the bootstrapped samples.</p>
                <p>Other analyses examining the missing data assumptions, the per-protocol population, using a reduced model, treatment effects within predefined clinical subgroups and exploratory descriptive statistics for selected secondary outcomes by COVID-19.</p>
              </sec>
              <sec id="s2-7">
                <title>Study monitoring</title>
                <p>A Trial Steering Committee (TSC) and Data Safety Monitoring Committee were appointed to independently review data on safety, protocol adherence and trial recruitment.</p>
              </sec>
              <sec id="s2-8">
                <title>Patient and public involvement</title>
                <p>Patient involvement began during protocol development and continued throughout the trial. A patient-member (not enrolled in the trial) attended TSC meetings. The same patient-member was a coinvestigator. He provided insights into the trial conduct, particularly on data collection processes and helped interpret the findings to inform the trial’s dissemination phase.</p>
                <p>Trial participants who expressed an interest in receiving information on the trial findings were provided with this.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <sec id="s3-1">
                <title>Recruitment and participant flow</title>
                <p>Recruitment occurred between 12 April 2019 and 27 March 2020. The Consolidated Standards of Reporting Trial<xref rid="R41" ref-type="bibr">41</xref> flowchart is presented as <xref rid="F1" ref-type="fig">figure 1</xref>. In total, 230 participants were randomised. Six were randomised in error, resulting in an analysable population of 224 participants (85 usual care; 139 experimental).</p>
                <p>Due to the COVID-19 pandemic, 47 participants that had consented to take part in the study could not be randomised and the trial was stopped 30 participants short of its planned sample size. All elective THRs and TKRs were cancelled as part of the UK national COVID-19 lockdown (23 March 2020). Group-based physiotherapy classes within the participating hospital outpatient settings (a mechanism this trial relied on for both treatment groups) were also halted. Consequently, it was not feasible to continue the trial for the final 30 planned participants.</p>
              </sec>
              <sec id="s3-2">
                <title>Retention</title>
                <p>The retention of participants is presented in <xref rid="F1" ref-type="fig">figure 1</xref>. There were 37 withdrawals (13 usual care; 24 experimental). <xref rid="SP1" ref-type="supplementary-material">Online supplemental file 1</xref> gives a summary of type of withdrawals by level of withdrawal and treatment group. The return of primary outcome data is presented in <xref rid="SP1" ref-type="supplementary-material">online supplemental table 2</xref>. This illustrates that for the primary, ITT, analysis of the UCLA Activity Score, there were 223 (99.6%) participants to supply a UCLA Activity Score at baseline (85 usual care; 138 experimental), 186 (83.0%) responses at 6 months (69 usual care; 117 experimental) and 181 (80.8%) responses at 12 months (70 usual care; 111 experimental).</p>
              </sec>
              <sec id="s3-3">
                <title>Participant characteristics</title>
                <p>Baseline characteristics are presented by randomised treatment group in <xref rid="T1" ref-type="table">table 1</xref>. The mean participant age was 68.4 years (SD: 8.7), 62.9% were women with 52.2% undergoing TKR. Seventy-four per cent of the cohort had a CCI of 1–3 (mean 2.9 (SD: 1.3)). Mean BMI was 30.9 kg/m<sup>2</sup> (SD: 5.7). The mean duration of symptoms prior to surgery was 46.9 months (SD: 50.9) with 73.2% presenting with an American Society of Anesthesiology grade of 2 at surgery. As <xref rid="T1" ref-type="table">table 1</xref> demonstrates, the two groups were comparable with the experimental group presenting with a slightly higher proportion of women (64.7% versus 60.0%), longer duration of symptoms (mean: 48.8 months versus 43.8 months) and fewer inactive participants (79.1% versus 83.5%) compared with the usual care group.</p>
                <table-wrap position="float" id="T1">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline characteristics by randomised group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Usual (n=85)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Experimental (n=139)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Total (n=224)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Age, years</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 68.5 (8.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 68.3 (8.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 68.4 (8.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> UCLA Activity Score, 1–10</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 3.6 (1.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 3.6 (1.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=223, 3.6 (1.5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">Joint replacement</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Hip replacement</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">40 (47.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">67 (48.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">107 (47.8)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Knee replacement</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">45 (52.9)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">72 (51.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">117 (52.2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">CCI, dichotomised</td>
                      </tr>
                      <tr>
                        <td align="char" char="ndash" valign="top" rowspan="1" colspan="1"> 1–3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">64 (75.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">102 (73.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">166 (74.1)</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"> 4+</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">21 (24.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">37 (26.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">58 (25.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> CCI, continuous</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 2.8 (1.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 3.0 (1.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 2.9 (1.3)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">Sex</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Female</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">51 (60.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">90 (64.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">141 (62.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Male</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">34 (40.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">49 (35.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">83 (37.1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">BMI, categories</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Healthy weight</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">15 (17.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">25 (18.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">40 (17.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Overweight</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">22 (25.9)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">45 (32.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">67 (29.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Obese</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">42 (49.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">60 (43.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">102 (45.5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Morbidly obese</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6 (7.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">9 (6.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">15 (6.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BMI, kg/m<sup>2</sup>
</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 31.1 (5.9)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 30.7 (5.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 30.9 (5.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">Joint pain in the past 7 days</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Yes</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">85 (100.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">138 (99.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">223 (99.6)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> No</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (0.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (0.4)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">GPPAQ level</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Active</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Moderately active</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (0.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (1.3)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Moderately inactive</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">12 (14.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">28 (20.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">40 (17.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Inactive</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">71 (83.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">110 (79.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">181 (80.8)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> AMTS</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 9.6 (0.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 9.6 (0.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 9.6 (0.6)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> EQ-5D-5L score</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 0.4 (0.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 0.4 (0.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 0.4 (0.2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> EQ-VAS, 0–100</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 61.3 (20.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 60.6 (23.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 60.9 (22.2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Numeric pain, 0–10</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 6.9 (1.9)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 7.2 (1.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=224, 7.1 (1.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Symptom duration, months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 43.8 (48.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 48.8 (52.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=223, 46.9 (50.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="4" rowspan="1">ASA classification</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"> 1</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">4 (4.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">12 (8.6)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">16 (7.1)</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"> 2</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">61 (71.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">103 (74.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">164 (73.2)</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"> 3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">20 (23.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">22 (15.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">42 (18.8)</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"> 4</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (1.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (0.9)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T1_FN1">
                      <p>Data are mean (SD) or n (%).+Stratification factor used in randomisation.</p>
                    </fn>
                    <fn id="T1_FN2">
                      <p>AMTS, Abbreviated Mental Test Score; ASA, American Society of Anesthesiologists; BMI, body mass index; CCI, Charlson Comorbidity Index; EQ-5D-5L, EuroQol 5-level; EQ-VAS, EuroQol Visual Analogue Scale; GPPAQ, General Practice Physical Activity Questionnaire; UCLA, University of California, Los Angeles.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s3-4">
                <title>Main analyses</title>
                <p>The results of the analysis for the primary outcome measure are presented in <xref rid="T2" ref-type="table">table 2</xref> and <xref rid="F2" ref-type="fig">figure 2</xref>. There was no evidence to support rejecting the null hypothesis that there was no difference between attending group-based exercise plus a group-based behaviour change intervention and attending group-based exercise alone on the UCLA Activity Score at 12 months postrandomisation, at the 5% significance level (mean difference: −0.03; 95% CI −0.52 to 0.45; p=0.89). However, as the trial could not reach its intended final sample size due to the COVID-19 pandemic, this result should be interpreted with caution. The interpretation of the results did not change on per-protocol analysis or reduced model analysis (<xref rid="SP1" ref-type="supplementary-material">online supplemental table 3</xref>; <xref rid="SP1" ref-type="supplementary-material">online supplemental table 4</xref>).</p>
                <table-wrap position="float" id="T2">
                  <label>Table 2</label>
                  <caption>
                    <p>UCLA Activity Score (primary outcome) results</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">Time point</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Usual</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Experimental</td>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">Mean difference</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">P value</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n, mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n, mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Unadjusted</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Adjusted (95% CI)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 3.62 (1.52)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 3.57 (1.57)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.06</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=69, 4.77 (1.52)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=117, 4.97 (1.68)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.20</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.27 (−0.21,0.76)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.27</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">12 months (primary outcome)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=70, 4.87 (1.61)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=111, 4.84 (1.91)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.03</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.03 (−0.52,0.45)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.89</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Area under the curve over 12 months</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.81 (0.29)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.89 (0.28)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.09 (-0.47,0.64)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.88</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">CACE: strict compliance</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=46</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.24 (−1.45,0.96)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.69</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">CACE: compliance</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=58</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.20 (−1.19,0.79)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.69</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">CACE: attendance</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=81</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.16 (−0.90,0.59)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.68</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T2_FN1">
                      <p>For the AUC analysis, the SD presented are the standard errors for these estimates calculated using the delta method. CACE analysis based on 10 000 bootstrapped samples.</p>
                    </fn>
                    <fn id="T2_FN2">
                      <p>AUC, area under the curve; CACE, complier average causal effect; n, number of participants; UCLA, University of California Los Angeles.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig position="float" id="F2">
                  <label>Figure 2</label>
                  <caption>
                    <p>UCLA Activity Score boxplots. UCLA, University of California Los Angeles.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2022-061373f02" position="float"/>
                </fig>
                <p>Three CACE estimations were performed on the 12 month UCLA Activity Score, one for each definition of compliance (Strict Compliance, Compliance and Attendance). <xref rid="T2" ref-type="table">Table 2</xref> presents the CACE estimates for the three levels of compliance. There was no difference in outcome based on these analyses and all effect estimates were within the MCID of 0.92.<xref rid="R34" ref-type="bibr">34</xref>
</p>
                <p>The results of all continuous secondary outcomes are presented in <xref rid="T3" ref-type="table">table 3</xref>. They demonstrate no significant between-group differences for any of the continuous secondary outcomes at any time point. A general pattern of improvement from baseline to 6 months, then levelling off at 12 months with no significant between-group differences observable, was seen throughout.</p>
                <table-wrap position="float" id="T3">
                  <label>Table 3</label>
                  <caption>
                    <p>Continuous secondary outcome results</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">Time point</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Usual</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Experimental</td>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">Mean difference</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">P value</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n, Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n, Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Unadjusted</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Adjusted (95% CI)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Lower Extremity Functional Scale</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=82, 23.72 (13.11)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=130, 24.50 (14.07)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.78</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=45, 45.40 (19.76)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=80, 51.44 (17.70)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6.04</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.60 (–3.29 to 8.50)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.39</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=51, 47.86 (18.97)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=80, 50.67 (21.40)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.81</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1.26 (–4.61 to 7.13)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.67</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Oxford Hip Score</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=40, 16.05 (6.36)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=67, 16.78 (7.99)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.73</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=28, 34.84 (11.73)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=50, 39.68 (8.93)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">4.84</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3.86 (–0.92 to 8.64)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.11</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=27, 36.90 (12.48)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=48, 39.42 (10.46)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.52</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.37 (–2.53 to 7.27)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.34</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Oxford Knee Score</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=45, 18.67 (8.51)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=72, 17.46 (6.99)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.21</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=33, 35.20 (7.62)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=51, 33.45 (9.38)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.75</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.74 (–5.03 to 1.54)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.30</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=35, 34.90 (8.46)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=55, 33.54 (9.84)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.36</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.43 (–4.72 to 1.86)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.39</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Numerical Rating Scale for Pain</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 6.87 (1.94)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 7.23 (1.79)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.36</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=61, 3.34 (2.59)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=101, 3.54 (2.74)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.20</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.19 (–0.64 to 1.02)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.66</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=61, 4.08 (2.87)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=102, 3.33 (2.85)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.75</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.75 (–1.59 to 0.09)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.08</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Generalised Self-Efficacy Scale</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=84, 31.31 (5.49)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 31.67 (5.39)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.36</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=58, 31.88 (5.18)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=98, 33.03 (5.30)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1.15</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1.15 (–0.30 to 2.61)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=61, 32.16 (5.55)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=101, 32.20 (6.72)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.03</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.33 (–1.13 to 1.78)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.66</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Tampa Scale for Kinesiophobia</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 40.04 (7.44)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=136, 39.77 (7.75)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.26</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=56, 35.77 (7.74)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=91, 34.77 (7.29)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.00</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.39 (–2.40 to 1.61)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.70</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=57, 36.56 (6.91)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=90, 35.06 (8.27)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.51</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.77 (–2.79 to 1.24)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.45</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Hospital Anxiety and Depression Scale (overall)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 11.85 (6.16)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 12.50 (7.07)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.65</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=59, 8.97 (6.52)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=97, 8.81 (6.36)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.15</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−1.18 (–2.73 to 0.37)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.14</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=62, 9.02 (6.61)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=98, 9.70 (6.99)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.69</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.52 (–1.03 to 2.06)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.51</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Hospital Anxiety and Depression Scale (anxiety)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 5.89 (3.78)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=138, 6.63 (4.07)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.74</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=60, 4.95 (4.01)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=98, 4.95 (3.57)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.00</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.71 (–1.67 to 0.25)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.15</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=62, 4.76 (3.73)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=99, 5.46 (3.84)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.71</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.36 (–0.60 to 1.31)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.46</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">Hospital Anxiety and Depression Scale (depression)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 5.95 (3.16)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 5.89 (3.81)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.06</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=61, 4.03 (3.27)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=99, 3.90 (3.51)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.13</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.25 (–1.13 to 0.63)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.58</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=62, 4.26 (3.47)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=101, 4.30 (4.02)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.04</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.24 (–0.65 to 1.12)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.60</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">EQ-5D-5L Index</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 0.40 (0.22)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 0.39 (0.27)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.01</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=68, 0.66 (0.23)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=117, 0.69 (0.25)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.03</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.03 (–0.03 to 0.10)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.31</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=70, 0.67 (0.24)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=113, 0.67 (0.29)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.00</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.00 (–0.06 to 0.07)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.93</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="6" rowspan="1">EQ-VAS</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Baseline</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=85, 61.33 (20.01)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=139, 60.58 (23.56)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.75</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 6 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=68, 70.93 (18.67)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=117, 73.86 (20.02)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.94</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2.84 (–2.31 to 7.99)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.28</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 12 months</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=69, 72.51 (17.90)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">n=110, 72.94 (19.98)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.43</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1.47 (–3.73 to 6.68)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.58</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T3_FN1">
                      <p>EQ-5D-5L, EuroQol 5-level; EQ-VAS, EuroQol Visual Analogue Scale.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>A total of 141 complications were reported from 75 participants, 50 (35.5%) in the usual care group and 91 (64.5%) in the experimental group (<xref rid="T4" ref-type="table">table 4</xref>; <xref rid="SP1" ref-type="supplementary-material">online supplemental figure 1</xref>). It should be noted that 62.1% of participants were randomised to the experimental group, so this apparent difference is expected if complication rate was the same across both groups. The most common complications were increased pain either in the operated joint or in other joints, wound infections, medical complications and stiffness in the operated joint. Most complications (65.2%) were reported in the first 6 months of postrandomisation. There was no difference in the number of people who had a complication (28 versus 47; OR: 1.03; 95% CI 0.56 to 1.89) or total numbers of complications (50 versus 91; OR: 1.10; 95% CI 0.77 to 1.56) between the usual care and experimental group, respectively. There was one adverse event (fall, usual care) and three serious adverse events (two experimental (cardiac failure, pneumonia), one usual care (suspected deep vein thrombosis)).</p>
                <table-wrap position="float" id="T4">
                  <label>Table 4</label>
                  <caption>
                    <p>Complication results</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Usual</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Experimental</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">OR<break/>(95% CI)</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">P value</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">N (%)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">N (%)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Number of participants who had a complication</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">28 (32.94)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">47 (33.81)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.03 (0.56 to 1.89)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.94</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Total complications</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">50 (58.82)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">91 (65.47)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.10 (0.77 to 1.56)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.61</td>
                      </tr>
                    </tbody>
                  </table>
                </table-wrap>
              </sec>
              <sec id="s3-5">
                <title>Analysis by compliance</title>
                <p>Treatment compliance is summarised in <xref rid="SP1" ref-type="supplementary-material">online supplemental figure 2</xref>. Compliance is reported by categories as defined in the analysis plan.<xref rid="R40" ref-type="bibr">40</xref> In total, 489 experimental intervention or physiotherapy exercise sessions were held. The sessions ran from 8 May 2019 to 18 March 2020. Of 162 were experimental sessions and 327 were exercise alone sessions (161 usual care; 166 experimental). There was one experimental class that was not accompanied by a physiotherapy class.</p>
                <p>A major component of the definition of compliance for the experimental group was the group class sizes. The median class size for the intervention classes was two with a range of 1–14. <xref rid="SP1" ref-type="supplementary-material">Online supplemental figure 3</xref> is a plot of the group sizes for all intervention sessions. Any class with three or more participants was considered a ‘compliant’ class. In total, 75 (46.3%) of the 162 intervention sessions had three or more participants. To address the issue of compliance, the randomisation procedure was changed from 1:1 to 2:1. <xref rid="SP1" ref-type="supplementary-material">Online supplemental figure 4</xref> is a breakdown of treatment compliance by participants randomised using either a 1:1 or 2:1 randomisation ratio. In both groups, the number of participants who were non-compliant rose considerably and the number of strict compliers fell after the change from 1:1 to 2:1 randomisation. A confounder to this result is that participants whose intervention was disrupted by COVID-19 were all randomised using a 2:1 ratio. The large increase in non-compliance in that population is seen in <xref rid="SP1" ref-type="supplementary-material">online supplemental figure 4</xref>.</p>
              </sec>
              <sec id="s3-6">
                <title>Impact of COVID-19 on trial findings</title>
                <p>The level of disruption to the intervention delivery caused by the COVID-19 pandemic was high. There was a high level of non-compliance, particularly in the experimental group. This apparent between-group difference in non-compliance was because the predefined definitions of compliance were stricter in the experimental than the usual care group. To be an ‘Attender’ in the experimental group, one needed to attend four out of six group intervention sessions, to achieve the same level of compliance in the usual care group, only one session was required to be attended. In the usual care group, 66 (77.6%) attended at least one physiotherapy session, a similar proportion, 111 (80%), attended at least one physiotherapy session in the experimental group. Due to the added therapy the experimental group received, the definition for compliance had to be stricter, but both groups had a similar proportion who attended at least one session.</p>
                <p>The final months of the trial, before all group-based physiotherapy classes within the hospital outpatient setting were halted due to the COVID-19 pandemic, yielded the highest group sizes. <xref rid="SP1" ref-type="supplementary-material">online Supplementary Figure 4</xref> summarises the compliance to the experimental group by pre-COVID-19 compared with COVID-19 to estimate the impact of the pandemic on compliance. This is plotted by time in <xref rid="SP1" ref-type="supplementary-material">online supplementary file 3</xref>. Based on this, a large proportion of participants who could not be randomised due to the trial closure would have ended up falling into either the ‘Compliant’ or ‘Strict Compliant’ groups.</p>
              </sec>
              <sec id="s3-7">
                <title>Additional analyses</title>
                <p>The missing data analysis suggests that the missing at random assumption made in the primary analysis is appropriate (<xref rid="SP1" ref-type="supplementary-material">online supplementary figure 5</xref>). The per-protocol and reduced model results support the main findings from the trial and there was no evidence of any difference in the exploratory subgroup analysis. The exploratory descriptive statistics by COVID-19 status may suggest participants in the COVID-19 group had poorer psychological outcomes (<xref rid="SP1" ref-type="supplementary-material">online supplementary table 5</xref>). The results are presented in full in <xref rid="SP1" ref-type="supplementary-material">online supplemental figure 6</xref>.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>The findings suggest that following THR or TKR, there is no difference between the addition of a group-based exercise and behaviour change intervention in physical activity and other clinical outcomes during the first postoperative year compared with attending group-based exercise alone. However, the COVID-19 pandemic significantly impacted on this trial, whereby the intended sample size was not achieved, and a considerable proportion of participants were unable to receive their intended postoperative rehabilitation. Accordingly, these findings should be interpreted with caution.</p>
              <p>The rationale for undertaking this study was the uncertainty over how to increase physical activity following THR and TKR. While several studies have been published over the intervening period acknowledging that physical activity remains low following joint replacement,<xref rid="R42" ref-type="bibr">42–44</xref> there continues to be uncertainty over how to overcome this. Studies in other populations, most notably older adults, individuals with chronic respiratory disorders and those with chronic rheumatological diseases have provided promise that a behaviour change intervention may improve physical activity.<xref rid="R17" ref-type="bibr">17–20</xref> As previously acknowledged, the specific challenges which individuals face in relation to fear avoidance, beliefs about implant failure, multijoint pain and other comorbidities<xref rid="R6" ref-type="bibr">6</xref> may account for why this behaviour change intervention did not demonstrate similar changes. However, this trial specifically relates to the effectiveness of a behaviour intervention targeted to the behaviour change construct of self-efficacy in the joint replacement population. There may remain value for future research exploring the effectiveness of other behaviour change constructs, to increase physical activity after these orthopaedic procedures. Furthermore, the results from this trial have been impacted by the COVID-19 pandemic, principally on intervention delivery and compliance. Given the impact COVID-19 had, there still remains a need to better understand how to increase physical activity following THR or TKR.</p>
              <p>Trial participants understood the research objective was to explore the effectiveness of an intervention aimed at increasing physical activity following THR or TKR. However, compliance to the intervention was low throughout the trial. Accordingly, the appetite to increase physical activity remains uncertain. Previous literature has suggested that while individuals may be no more physically active after joint replacement,<xref rid="R44" ref-type="bibr">44 45</xref> clinical outcomes and specifically pain do significantly improve.<xref rid="R46" ref-type="bibr">46 47</xref> This corresponds with an improvement in HRQoL. Patient satisfaction to outcome and expectations may be met, but this is not translated into increased physical activity. Given the wider health benefits which physical activity confers, consideration should be made on how health professionals promote physical activity messages within postoperative recovery programmes, so added health gains are maximised. How this is operationalised following this trial’s findings remains unclear.</p>
              <p>While the results indicate no superiority to the addition of a behaviour change intervention to usual physiotherapy rehabilitation after TKR or THR, the findings offer important clinical implications. First, the trial indicates that joint replacement and usual physiotherapy rehabilitation can improve clinical outcomes. Previous literature suggests improvements in pain, function and HRQoL<xref rid="R46" ref-type="bibr">46 47</xref> for people following THR and TKR. However, the trial also indicates both pre-COVID-19 and post-COVID-19 that there were differences in adherence and compliance to both usual and experimental physiotherapy interventions. While previous literature has highlighted geographical and service-provision differences in rehabilitation after joint replacement,<xref rid="R48" ref-type="bibr">48 49</xref> there has been limited evidence to indicate variability in adherence to rehabilitation. This may reflect variation in rehabilitation need. While some patients may need substantial levels of physiotherapy following joint replacement to promote physical function, activity and improvements in HRQoL, these may not be homogeneous within the population.<xref rid="R50" ref-type="bibr">50</xref> Stratification on rehabilitation need may, therefore, be warranted. While previous authors have attempted to identify those at most risk of poor outcomes postoperative,<xref rid="R51" ref-type="bibr">51 52</xref> there remains uncertainty over what physiotherapy intervention is more beneficial for these patients. Further consideration on the optimal rehabilitation programme to promote physical activity for those with the most to gain as opposed to assuming all, as adopted in this trial, may be indicated.</p>
              <p>There are several trial strengths and limitations to be considered. A major strength was the pragmatic approach taken to assess effectiveness. The broad eligibility criteria to reflect typical patients who undergo THR and TKR, balanced by the inclusion of only those, who were preoperatively moderately inactive or inactive, meant the eligibility criteria were constructed to theoretically recruit those who had the most to gain. The multisite, national recruitment process across NHS health trusts also offered the ability to recruit a diverse cohort in relation to socioeconomic, ethnic and geographical factors. However, a limitation to the design was that several measures which may have characterised such diversity including level of deprivation, educational status, ethnicity and educational background were not collected. This decision was made to offer a more efficient data collection process, not overburdening participants with extensive demographic data requests. Smith <italic toggle="yes">et al</italic>
<xref rid="R53" ref-type="bibr">53</xref> previously acknowledged that this as a recurrent limitation to musculoskeletal research. Future research should consider the impact of socioeconomic and deprivation factors both on the design of interventions, processes and analysis. A further limitation was the impact of COVID-19. While acknowledged that the trial over-recruited, consenting 277 participants, only 230 were randomised as the pandemic disrupted surgical and rehabilitation delivery. This means that the results were underpowered to answer the trial’s primary research question. Second, 69 individuals who were receiving rehabilitation during this time had their intervention delivery impacted on this change in service provision. Consequently, intervention compliance reduced, impacting on any effect estimate generated from that point onwards. Given this equated to 30% of the cohort, it is proposed this had a significant impact. What is more difficult to estimate is the impact of the COVID-19 social restrictions on outcome. All participants experienced the 2020 social restrictions prior to completing their 12-month questionnaires (first 12-month questionnaire completed 23 March 2020). While previous studies<xref rid="R54" ref-type="bibr">54 55</xref> indicate that individuals with joint pain substantially reduced their natural physical activity engagement during this time, we did not specifically collect data to ascertain the effects of ‘lockdown’ on outcomes. The effect of this on 12-month results should, therefore, be considered.</p>
            </sec>
            <sec sec-type="conclusions" id="s5">
              <title>Conclusions</title>
              <p>The addition of a group-based behaviour change intervention to usual physiotherapy rehabilitation following primary THR and TKR does not offer benefit over usual physiotherapy alone on physical activity and clinical outcomes over the first 12 postoperative months. These findings should be viewed with caution as the COVID-19 pandemic impacted on both the ability of participants to undergo joint replacement and compliance to their rehabilitation. Given the health and social benefits which being active offer older adults, further exploration on methods to increase physical activity for those who are inactive following joint replacement remains important.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="d64e298">
                <caption>
                  <title>Reviewer comments</title>
                </caption>
                <media xlink:href="bmjopen-2022-061373.reviewer_comments.pdf"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="d64e299">
                <caption>
                  <title>Author's
manuscript</title>
                </caption>
                <media xlink:href="bmjopen-2022-061373.draft_revisions.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Twitter:</bold> @tobyosmith, @bethanyfordham</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Collaborators:</bold> PEP-TALK Collaborators: Mr Steve Algar (Banbury, PPI Representative), Dr Zara Hansen (ZH) (University of Oxford), Dr Vicki Barber (Oxford Clinical Trials Research Unit (OCTRU), University of Oxford), Mr Malcolm Hart (OCTRU), University of Oxford), May Ee Png (OCTRU, University of Oxford), Professor Karen Barker (Principal Investigator—Oxford University Hospital NHS Foundation Trust (OUH), Mr Ian Smith (Principal Investigator—Lewisham and Greenwich University Hospitals NHS Foundation Trust), Professor Iain McNamara (Principal Investigator (Norfolk and Norwich University Hospitals NHS Foundation Trust (NNUH) &amp; Spire Norwich), Mr Michael Dunn (Principal Investigator - St George’s University Hospital NHS Foundation Trust), Mrs Dawn Lockey (Principal Investigator—City Hospitals Sunderland NHS Foundation Trust), Mr Sonny Driver (Principal Investigator—North Middlesex University Hospital NHS Trust), Mrs Jamila Kassam (Barts Health NHS Trust), Mr Peter Penny (Norwich Spire, Norwich), Mrs Celia Woodhouse, Mrs Tracey Potter and Mrs Helena Daniell (NNUH), Mr Alex Herring and Mrs Yan Cunningham (City Hospitals Sunderland NHS Foundation Trust), Irrum Afzal (South West London Elective Orthopaedic Centre), Mr Maninderpal Matharu (Barts Health NHS Trust) and Mrs Tamsin Hughes, Ms Erin Hannink and Mrs Michelle Moynihan (OUH).</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> TOS, BF, SD, SL, AO, CH, AG, SP researched the topic and devised the study. TOS, SP, AO, BF, SD, CH, AG, SL provided the first draft of the manuscript. AO, SD provided statistical analysis and oversight. TOS, SP, BF, AO, SD, CH, AG, SL contributed equally to manuscript preparation. TS acts a guarantor.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> The research is supported by the National Institute for Health Research (NIHR) Research for Patient Benefit grant (PB-PG-1216-20008). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p>
              </fn>
            </fn-group>
            <sec sec-type="data-availability">
              <title>Data availability statement</title>
              <p>Data are available upon reasonable request. Access to the de-identified dataset for purposes of research other than this study, would be at the discretion of the Chief Investigator, Dr Toby Smith and OCTRU. Requests for the de-identified dataset generated during the current study should be made to the Chief Investigator, Dr Toby Smith (email: toby.smith@uea.ac.uk) or OCTRU (octrutrialshub@ndorms.ox.ac.uk). Dr Toby Smith and OCTRU will consider requests once the main results from the study have been published up until 31 December 2026.</p>
            </sec>
            <sec sec-type="ethics-statement">
              <title>Ethics statements</title>
              <sec>
                <title>Patient consent for publication</title>
                <p content-type="ethics-consent-to-publish">Not applicable.</p>
              </sec>
              <sec>
                <title>Ethics approval</title>
                <p content-type="ethics-approval">This study involves human participants and was approved by NHS NRES South Central Oxford B (18/SC/0423). Participants gave informed consent to participate in the study before taking part.</p>
              </sec>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Joint Registry</collab></person-group>. <article-title>18Th annual report</article-title>. <source>NJR 18th annual report 2021.pdf</source>. Available: <uri xlink:href="(njrcentre.org.uk)">(njrcentre.org.uk)</uri> [Accessed <comment>19 Dec 2020</comment>].</mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dailiana</surname><given-names>ZH</given-names></string-name>, <string-name><surname>Papakostidou</surname><given-names>I</given-names></string-name>, <string-name><surname>Varitimidis</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Patient-Reported quality of life after primary major joint arthroplasty: a prospective comparison of hip and knee arthroplasty</article-title>. <source>BMC Musculoskelet Disord</source><year>2015</year>;<volume>16</volume>:<elocation-id>366</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12891-015-0814-9</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26612135?><pub-id pub-id-type="pmid">26612135</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Papakostidou</surname><given-names>I</given-names></string-name>, <string-name><surname>Dailiana</surname><given-names>ZH</given-names></string-name>, <string-name><surname>Papapolychroniou</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Factors affecting the quality of life after total knee arthroplasties: a prospective study</article-title>. <source>BMC Musculoskelet Disord</source><year>2012</year>;<volume>13</volume>:<elocation-id>116</elocation-id>. <pub-id pub-id-type="doi">10.1186/1471-2474-13-116</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/22748117?><pub-id pub-id-type="pmid">22748117</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Withers</surname><given-names>TM</given-names></string-name>, <string-name><surname>Lister</surname><given-names>S</given-names></string-name>, <string-name><surname>Sackley</surname><given-names>C</given-names></string-name></person-group>. <article-title>Is there a difference in physical activity levels in patients before and up to one year after unilateral total hip replacement? A systematic review and meta-analysis</article-title>. <source>Clin Rehabil</source><year>2017</year>;<volume>316</volume>:<fpage>39</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1177/0269215516673884</pub-id>
</mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Hilton</surname><given-names>G</given-names></string-name>, <string-name><surname>Mansfield</surname><given-names>M</given-names></string-name></person-group>. <article-title>Does physical activity change following hip and knee arthroplasty? an analysis of data from the osteoarthritis initiative</article-title>. <source>Physiotherapy</source><year>2018</year>;<volume>104</volume>:<fpage>80</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.physio.2017.02.001</pub-id>
<pub-id pub-id-type="pmid">28917522</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Latham</surname><given-names>S</given-names></string-name>, <string-name><surname>Maskrey</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Patients' perceptions of physical activity before and after joint replacement: a systematic review with meta-ethnographic analysis</article-title>. <source>Postgrad Med J</source><year>2015</year>;<volume>91</volume>:<fpage>483</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1136/postgradmedj-2015-133507</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26306502?><pub-id pub-id-type="pmid">26306502</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Inacio</surname><given-names>MCS</given-names></string-name>, <string-name><surname>Pratt</surname><given-names>NL</given-names></string-name>, <string-name><surname>Roughead</surname><given-names>EE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson measures: a cross-sectional evaluation</article-title>. <source>BMC Musculoskelet Disord</source><year>2015</year>;<volume>16</volume>:<elocation-id>385</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12891-015-0835-4</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26652166?><pub-id pub-id-type="pmid">26652166</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peter</surname><given-names>WF</given-names></string-name>, <string-name><surname>Dekker</surname><given-names>J</given-names></string-name>, <string-name><surname>Tilbury</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The association between comorbidities and pain, physical function and quality of life following hip and knee arthroplasty</article-title>. <source>Rheumatol Int</source><year>2015</year>;<volume>35</volume>:<fpage>1233</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-015-3211-7</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/25586654?><pub-id pub-id-type="pmid">25586654</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>E</given-names></string-name>, <string-name><surname>Hoy</surname><given-names>DG</given-names></string-name>, <string-name><surname>Cross</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The global burden of other musculoskeletal disorders: estimates from the global burden of disease 2010 study</article-title>. <source>Ann Rheum Dis</source><year>2014</year>;<volume>73</volume>:<fpage>1462</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204680</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/24590181?><pub-id pub-id-type="pmid">24590181</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sampson</surname><given-names>UKA</given-names></string-name>, <string-name><surname>Fowkes</surname><given-names>FGR</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010</article-title>. <source>Glob Heart</source><year>2014</year>;<volume>9</volume>:<elocation-id>e21</elocation-id>:<fpage>145</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.gheart.2013.12.008</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/25432124?></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>CD</given-names></string-name>, <string-name><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name><surname>Blair</surname><given-names>SN</given-names></string-name></person-group>. <article-title>Physical activity and stroke risk: a meta-analysis</article-title>. <source>Stroke</source><year>2003</year>;<volume>34</volume>:<fpage>2475</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.0000091843.02517.9D</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/14500932?><pub-id pub-id-type="pmid">14500932</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Laaksonen</surname><given-names>DE</given-names></string-name>, <string-name><surname>Lindström</surname><given-names>J</given-names></string-name>, <string-name><surname>Lakka</surname><given-names>TA</given-names></string-name></person-group>. <article-title>Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study</article-title>. <source>Diabetes</source><year>2005</year>;<volume>54</volume>:<fpage>158</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.54.1.158</pub-id>
<pub-id pub-id-type="pmid">15616024</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>I-M</given-names></string-name></person-group>. <article-title>Physical activity and cancer prevention--data from epidemiologic studies</article-title>. <source>Med Sci Sports Exerc</source><year>2003</year>;<volume>35</volume>:<fpage>1823</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1249/01.MSS.0000093620.27893.23</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/14600545?><pub-id pub-id-type="pmid">14600545</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kersten</surname><given-names>RFMR</given-names></string-name>, <string-name><surname>Stevens</surname><given-names>M</given-names></string-name>, <string-name><surname>van Raay</surname><given-names>JJAM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Habitual physical activity after total knee replacement</article-title>. <source>Phys Ther</source><year>2012</year>;<volume>92</volume>:<fpage>1109</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.2522/ptj.20110273</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/22628580?><pub-id pub-id-type="pmid">22628580</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Guideline Centre (UK)</collab></person-group>. <source>Evidence review for information needs: joint replacement (primary): hip, knee and shoulder: evidence review a</source>. <publisher-loc>London</publisher-loc>: <publisher-name>National Institute for Health and Care Excellence (UK)</publisher-name>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>French</surname><given-names>DP</given-names></string-name>, <string-name><surname>Olander</surname><given-names>EK</given-names></string-name>, <string-name><surname>Chisholm</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Which behaviour change techniques are most effective at increasing older adults' self-efficacy and physical activity behaviour? A systematic review</article-title>. <source>Ann Behav Med</source><year>2014</year>;<volume>48</volume>:<fpage>225</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1007/s12160-014-9593-z</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/24648017?><pub-id pub-id-type="pmid">24648017</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O'Dwyer</surname><given-names>T</given-names></string-name>, <string-name><surname>Monaghan</surname><given-names>A</given-names></string-name>, <string-name><surname>Moran</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Behaviour change intervention increases physical activity, spinal mobility and quality of life in adults with ankylosing spondylitis: a randomised trial</article-title>. <source>J Physiother</source><year>2017</year>;<volume>63</volume>:<fpage>30</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphys.2016.11.009</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27989730?><pub-id pub-id-type="pmid">27989730</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burkow</surname><given-names>TM</given-names></string-name>, <string-name><surname>Vognild</surname><given-names>LK</given-names></string-name>, <string-name><surname>Johnsen</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Promoting exercise training and physical activity in daily life: a feasibility study of a virtual group intervention for behaviour change in COPD</article-title>. <source>BMC Med Inform Decis Mak</source><year>2018</year>;<volume>18</volume>:<elocation-id>136</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12911-018-0721-8</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30563507?><pub-id pub-id-type="pmid">30563507</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boulton</surname><given-names>E</given-names></string-name>, <string-name><surname>Hawley-Hague</surname><given-names>H</given-names></string-name>, <string-name><surname>French</surname><given-names>DP</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Implementing behaviour change theory and techniques to increase physical activity and prevent functional decline among adults aged 61-70: the PreventIT project</article-title>. <source>Prog Cardiovasc Dis</source><year>2019</year>;<volume>62</volume>:<fpage>147</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2019.01.003</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30685469?><pub-id pub-id-type="pmid">30685469</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samdal</surname><given-names>GB</given-names></string-name>, <string-name><surname>Eide</surname><given-names>GE</given-names></string-name>, <string-name><surname>Barth</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses</article-title>. <source>Int J Behav Nutr Phys Act</source><year>2017</year>;<volume>14</volume>:<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s12966-017-0494-y</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28351367?><pub-id pub-id-type="pmid">28351367</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Parsons</surname><given-names>S</given-names></string-name>, <string-name><surname>Fordham</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Behaviour change physiotherapy intervention to increase physical activity following hip and knee replacement (PEP-TALK): study protocol for a pragmatic randomised controlled trial</article-title>. <source>BMJ Open</source><year>2020</year>;<volume>10</volume>:<elocation-id>e035014</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2019-035014</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32690503?></mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="webpage"><article-title>Department of health</article-title>, <year>2013</year>. Available: <uri xlink:href="https://www.gov.uk/government/publications/general-practice-physical-activity-questionnaire-gppaq">https://www.gov.uk/government/publications/general-practice-physical-activity-questionnaire-gppaq</uri> [Accessed <comment>21 Feb 2017</comment>].</mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Charlson</surname><given-names>ME</given-names></string-name>, <string-name><surname>Pompei</surname><given-names>P</given-names></string-name>, <string-name><surname>Ales</surname><given-names>KL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis</source><year>1987</year>;<volume>40</volume>:<fpage>373</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/3558716?><pub-id pub-id-type="pmid">3558716</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Charlson</surname><given-names>M</given-names></string-name>, <string-name><surname>Charlson</surname><given-names>RE</given-names></string-name>, <string-name><surname>Briggs</surname><given-names>W</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Can disease management target patients most likely to generate high costs? the impact of comorbidity</article-title>. <source>J Gen Intern Med</source><year>2007</year>;<volume>22</volume>:<fpage>464</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s11606-007-0130-7</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/17372794?><pub-id pub-id-type="pmid">17372794</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hodkinson</surname><given-names>HM</given-names></string-name></person-group>. <article-title>Evaluation of a mental test score for assessment of mental impairment in the elderly</article-title>. <source>Age Ageing</source><year>1972</year>;<volume>1</volume>:<fpage>233</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/ageing/1.4.233</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/4669880?><pub-id pub-id-type="pmid">4669880</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Bandura</surname><given-names>A</given-names></string-name></person-group>. <source>Social foundations of thought and action</source>. <volume>A social cognitive theory</volume>. <publisher-name>Prentice-Hall Inc</publisher-name>, <year>1986</year>.</mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arnautovska</surname><given-names>U</given-names></string-name>, <string-name><surname>O'Callaghan</surname><given-names>F</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>K</given-names></string-name></person-group>. <article-title>Applying the integrated behavior change model to understanding physical activity among older adults: a qualitative study</article-title>. <source>J Sport Exerc Psychol</source><year>2017</year>;<volume>39</volume>:<fpage>43</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1123/jsep.2015-0330</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28573943?><pub-id pub-id-type="pmid">28573943</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olanrewaju</surname><given-names>O</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>S</given-names></string-name>, <string-name><surname>Cowan</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Physical activity in community dwelling older people: a systematic review of reviews of interventions and context</article-title>. <source>PLoS One</source><year>2016</year>;<volume>11</volume>:<elocation-id>e0168614</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0168614</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27997604?><pub-id pub-id-type="pmid">27997604</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Devereux-Fitzgerald</surname><given-names>A</given-names></string-name>, <string-name><surname>Powell</surname><given-names>R</given-names></string-name>, <string-name><surname>Dewhurst</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The acceptability of physical activity interventions to older adults: a systematic review and meta-synthesis</article-title>. <source>Soc Sci Med</source><year>2016</year>;<volume>158</volume>:<fpage>14</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.socscimed.2016.04.006</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/27104307?><pub-id pub-id-type="pmid">27104307</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zahiri</surname><given-names>CA</given-names></string-name>, <string-name><surname>Schmalzried</surname><given-names>TP</given-names></string-name>, <string-name><surname>Szuszczewicz</surname><given-names>ES</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Assessing activity in joint replacement patients</article-title>. <source>J Arthroplasty</source><year>1998</year>;<volume>13</volume>:<fpage>890</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/S0883-5403(98)90195-4</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/9880181?><pub-id pub-id-type="pmid">9880181</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naal</surname><given-names>FD</given-names></string-name>, <string-name><surname>Impellizzeri</surname><given-names>FM</given-names></string-name>, <string-name><surname>Leunig</surname><given-names>M</given-names></string-name></person-group>. <article-title>Which is the best activity rating scale for patients undergoing total joint arthroplasty?</article-title><source>Clin Orthop Relat Res</source><year>2009</year>;<volume>467</volume>:<fpage>958</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1007/s11999-008-0358-5</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/18587624?><pub-id pub-id-type="pmid">18587624</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>SooHoo</surname><given-names>NF</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name><surname>Chenok</surname><given-names>KE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Responsiveness of patient reported outcome measures in total joint arthroplasty patients</article-title>. <source>J Arthroplasty</source><year>2015</year>;<volume>30</volume>:<fpage>176</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.arth.2014.09.026</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/25449591?><pub-id pub-id-type="pmid">25449591</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binkley</surname><given-names>JM</given-names></string-name>, <string-name><surname>Stratford</surname><given-names>OW</given-names></string-name>, <string-name><surname>Lott</surname><given-names>SA</given-names></string-name></person-group>. <article-title>The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application</article-title>. <source>Phys Ther</source><year>1999</year>;<volume>79</volume>:<fpage>371</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">10201543</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>J</given-names></string-name>, <string-name><surname>Fitzpatrick</surname><given-names>R</given-names></string-name>, <string-name><surname>Carr</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Questionnaire on the perceptions of patients about total hip replacement</article-title>. <source>J Bone Joint Surg Br</source><year>1996</year>;<volume>78</volume>:<fpage>185</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1302/0301-620X.78B2.0780185</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/8666621?><pub-id pub-id-type="pmid">8666621</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawson</surname><given-names>J</given-names></string-name>, <string-name><surname>Fitzpatrick</surname><given-names>R</given-names></string-name>, <string-name><surname>Murray</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Questionnaire on the perceptions of patients about total knee replacement</article-title>. <source>J Bone Joint Surg Br</source><year>1998</year>;<volume>80</volume>:<fpage>63</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1302/0301-620X.80B1.0800063</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/9460955?><pub-id pub-id-type="pmid">9460955</pub-id></mixed-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Schwarzer</surname><given-names>R</given-names></string-name>, <string-name><surname>Jerusalem</surname><given-names>M</given-names></string-name></person-group>. <part-title>Generalized Self-Efficacy scale</part-title>. In: <person-group person-group-type="editor"><string-name><surname>Weinman</surname><given-names>J</given-names></string-name>, <string-name><surname>Wright</surname><given-names>S</given-names></string-name>, <string-name><surname>Johnston</surname><given-names>M</given-names></string-name></person-group>, eds. <source>Measures in health psychology: a user's portfolio. causal and control beliefs</source>, <year>1995</year>: <fpage>35</fpage>–<lpage>7</lpage>.</mixed-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miller</surname><given-names>RP</given-names></string-name>, <string-name><surname>Kori</surname><given-names>S</given-names></string-name>, <string-name><surname>Todd</surname><given-names>D</given-names></string-name></person-group>. <article-title>The Tampa scale: a measure of kinesiophobia</article-title>. <source>Clin J Pain</source><year>1991</year>;<volume>7</volume>:<fpage>51</fpage>–<lpage>2</lpage>.</mixed-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zigmond</surname><given-names>AS</given-names></string-name>, <string-name><surname>Snaith</surname><given-names>RP</given-names></string-name></person-group>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source><year>1983</year>;<volume>67</volume>:<fpage>361</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1983.tb09716.x</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/6880820?><pub-id pub-id-type="pmid">6880820</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>EuroQol Group E</given-names></string-name>, <collab>EuroQol Group</collab></person-group>. <article-title>EuroQol--a new facility for the measurement of health-related quality of life</article-title>. <source>Health Policy</source><year>1990</year>;<volume>16</volume>:<fpage>199</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/0168-8510(90)90421-9</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/10109801?><pub-id pub-id-type="pmid">10109801</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ooms</surname><given-names>A</given-names></string-name>, <string-name><surname>Dutton</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Parsons</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Statistical analysis plan for a pragmatic phase III randomised controlled trial examining behaviour change physiotherapy intervention to increase physical activity following hip and knee replacements: the PEP-TALK trial</article-title>. <source>Trials</source><year>2021</year>;<volume>22</volume>:<elocation-id>467</elocation-id>. <pub-id pub-id-type="doi">10.1186/s13063-021-05362-x</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34284802?><pub-id pub-id-type="pmid">34284802</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schulz</surname><given-names>KF</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name><surname>Moher</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Consort 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMC Med</source><year>2010</year>;<volume>8</volume>:<elocation-id>18</elocation-id>. <pub-id pub-id-type="doi">10.1186/1741-7015-8-18</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/20334633?><pub-id pub-id-type="pmid">20334633</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fawaz</surname><given-names>WS</given-names></string-name>, <string-name><surname>Masri</surname><given-names>BA</given-names></string-name></person-group>. <article-title>Allowed activities after primary total knee arthroplasty and total hip arthroplasty</article-title>. <source>Orthop Clin North Am</source><year>2020</year>;<volume>51</volume>:<fpage>441</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.ocl.2020.06.002</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32950213?><pub-id pub-id-type="pmid">32950213</pub-id></mixed-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luna</surname><given-names>IE</given-names></string-name>, <string-name><surname>Kehlet</surname><given-names>H</given-names></string-name>, <string-name><surname>Wede</surname><given-names>HR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Objectively measured early physical activity after total hip or knee arthroplasty</article-title>. <source>J Clin Monit Comput</source><year>2019</year>;<volume>33</volume>:<fpage>509</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s10877-018-0185-5</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30039461?><pub-id pub-id-type="pmid">30039461</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hawke</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Shields</surname><given-names>N</given-names></string-name>, <string-name><surname>Dowsey</surname><given-names>MM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Physical activity levels after hip and knee joint replacement surgery: an observational study</article-title>. <source>Clin Rheumatol</source><year>2019</year>;<volume>38</volume>:<fpage>665</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-018-4317-6</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30284079?><pub-id pub-id-type="pmid">30284079</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Witjes</surname><given-names>S</given-names></string-name>, <string-name><surname>Gouttebarge</surname><given-names>V</given-names></string-name>, <string-name><surname>Kuijer</surname><given-names>PPFM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Return to sports and physical activity after total and unicondylar knee arthroplasty: a systematic review and meta-analysis</article-title>. <source>Sports Med</source><year>2016</year>;<volume>46</volume>:<fpage>269</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-015-0421-9</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/26744336?><pub-id pub-id-type="pmid">26744336</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hamel</surname><given-names>MB</given-names></string-name>, <string-name><surname>Toth</surname><given-names>M</given-names></string-name>, <string-name><surname>Legedza</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes</article-title>. <source>Arch Intern Med</source><year>2008</year>;<volume>168</volume>:<fpage>1430</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1001/archinte.168.13.1430</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/18625924?><pub-id pub-id-type="pmid">18625924</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ethgen</surname><given-names>O</given-names></string-name>, <string-name><surname>Bruyère</surname><given-names>O</given-names></string-name>, <string-name><surname>Richy</surname><given-names>F</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Health-Related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature</article-title>. <source>J Bone Joint Surg Am</source><year>2004</year>;<volume>86</volume>:<fpage>963</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.2106/00004623-200405000-00012</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/15118039?><pub-id pub-id-type="pmid">15118039</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Dainty</surname><given-names>JR</given-names></string-name>, <string-name><surname>Clark</surname><given-names>EM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Demographic and geographical variability in physiotherapy provision following hip and knee replacement. An analysis from the National joint Registry for England, Wales, Northern Ireland and the Isle of man</article-title>. <source>Physiotherapy</source><year>2020</year>;<volume>106</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.physio.2019.11.003</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32026841?><pub-id pub-id-type="pmid">32026841</pub-id></mixed-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garriga</surname><given-names>C</given-names></string-name>, <string-name><surname>Leal</surname><given-names>J</given-names></string-name>, <string-name><surname>Sánchez-Santos</surname><given-names>MT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Geographical variation in outcomes of primary hip and knee replacement</article-title>. <source>JAMA Netw Open</source><year>2019</year>;<volume>2</volume>:<elocation-id>e1914325</elocation-id>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.14325</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31664449?><pub-id pub-id-type="pmid">31664449</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fleischman</surname><given-names>AN</given-names></string-name>, <string-name><surname>Crizer</surname><given-names>MP</given-names></string-name>, <string-name><surname>Tarabichi</surname><given-names>M</given-names></string-name></person-group>. <article-title>John N. Insall Award: recovery of knee flexion with unsupervised home exercise is not inferior to outpatient physical therapy after TKA: a randomized trial</article-title>. <source>Clin Orthop Relat Res</source><year>2018</year>;<volume>2019</volume>:<fpage>60</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/CORR.0000000000000561</pub-id>
</mixed-citation>
              </ref>
              <ref id="R51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hamilton</surname><given-names>DF</given-names></string-name>, <string-name><surname>Beard</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Barker</surname><given-names>KL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Targeting rehabilitation to improve outcomes after total knee arthroplasty in patients at risk of poor outcomes: randomised controlled trial</article-title>. <source>BMJ</source><year>2020</year>;<volume>371</volume>:<elocation-id>m3576</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.m3576</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/33051212?><pub-id pub-id-type="pmid">33051212</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barker</surname><given-names>KL</given-names></string-name>, <string-name><surname>Room</surname><given-names>J</given-names></string-name>, <string-name><surname>Knight</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Home-Based rehabilitation programme compared with traditional physiotherapy for patients at risk of poor outcome after knee arthroplasty: the CORKA randomised controlled trial</article-title>. <source>BMJ Open</source><year>2021</year>;<volume>11</volume>:<elocation-id>e052598</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2021-052598</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34452970?></mixed-citation>
              </ref>
              <ref id="R53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Kamper</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Williams</surname><given-names>CM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Reporting of social deprivation in musculoskeletal trials: an analysis of 402 randomised controlled trials</article-title>. <source>Musculoskeletal Care</source><year>2021</year>;<volume>19</volume>:<fpage>180</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/msc.1520</pub-id>
</mixed-citation>
              </ref>
              <ref id="R54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>TO</given-names></string-name>, <string-name><surname>Belderson</surname><given-names>P</given-names></string-name>, <string-name><surname>Dainty</surname><given-names>JR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study</article-title>. <source>BMJ Open</source><year>2021</year>;<volume>11</volume>:<elocation-id>e048772</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2021-048772</pub-id><?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/34083347?></mixed-citation>
              </ref>
              <ref id="R55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brady</surname><given-names>SM</given-names></string-name>, <string-name><surname>Fenton</surname><given-names>SAM</given-names></string-name>, <string-name><surname>Metsios</surname><given-names>GS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19</article-title>. <source>Rheumatol Int</source><year>2021</year>;<volume>41</volume>:<fpage>335</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-020-04751-w</pub-id>
<?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/33258004?><pub-id pub-id-type="pmid">33258004</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
